<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36635726</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>13</Day></PubDate></JournalIssue><Title>Molecular neurodegeneration</Title><ISOAbbreviation>Mol Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Advances in sequencing technologies for amyotrophic lateral sclerosis research.</ArticleTitle><Pagination><StartPage>4</StartPage><MedlinePgn>4</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13024-022-00593-1</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is caused by upper and lower motor neuron loss and has a fairly rapid disease progression, leading to fatality in an average of 2-5&#x2009;years after symptom onset. Numerous genes have been implicated in this disease; however, many cases remain unexplained. Several technologies are being used to identify regions of interest and investigate candidate genes. Initial approaches to detect ALS genes include, among others, linkage analysis, Sanger sequencing, and genome-wide association studies. More recently, next-generation sequencing methods, such as whole-exome and whole-genome sequencing, have been introduced. While those methods have been particularly useful in discovering new ALS-linked genes, methodological advances are becoming increasingly important, especially given the complex genetics of ALS. Novel sequencing technologies, like long-read sequencing, are beginning to be used to uncover the contribution of repeat expansions and other types of structural variation, which may help explain missing heritability in ALS. In this review, we discuss how popular and/or upcoming methods are being used to discover ALS genes, highlighting emerging long-read sequencing platforms and their role in aiding our understanding of this challenging disease.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Udine</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Angita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mayo Clinic Graduate School of Biomedical Sciences, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical and Translational Sciences, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Blitterswijk</LastName><ForeName>Marka</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3054-7053</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road S, Jacksonville, FL, 32224, USA. VanBlitterswijk.Marka@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS121125</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS123052</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS121125</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS123052</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>TL1 TR002380</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Neurodegener</MedlineTA><NlmUniqueID>101266600</NlmUniqueID><ISSNLinking>1750-1326</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">DNA sequencing</Keyword><Keyword MajorTopicYN="N">Long-read sequencing</Keyword><Keyword MajorTopicYN="N">Multi-omics</Keyword><Keyword MajorTopicYN="N">Nanopore sequencing</Keyword><Keyword MajorTopicYN="N">SMRT sequencing</Keyword></KeywordList><CoiStatement>Not applicable.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>12</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36635726</ArticleId><ArticleId IdType="pmc">PMC9838075</ArticleId><ArticleId IdType="doi">10.1186/s13024-022-00593-1</ArticleId><ArticleId IdType="pii">10.1186/s13024-022-00593-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP. Amyotrophic lateral sclerosis. Curr Opin Neurol. 1994;7(4):310&#x2013;315. doi: 10.1097/00019052-199408000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00019052-199408000-00006</ArticleId><ArticleId IdType="pubmed">7952238</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x201c;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J Neurol Sci. 1994;124(Suppl):96&#x2013;107. doi: 10.1016/0022-510X(94)90191-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90191-0</ArticleId><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology. 2005;25(3):144&#x2013;152. doi: 10.1159/000086679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000086679</ArticleId><ArticleId IdType="pubmed">15990445</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65(4):586&#x2013;590. doi: 10.1212/01.wnl.0000172911.39167.b6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000172911.39167.b6</ArticleId><ArticleId IdType="pubmed">16116120</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6(11):994&#x2013;1003. doi: 10.1016/S1474-4422(07)70265-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70265-X</ArticleId><ArticleId IdType="pubmed">17945153</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10(5-6):310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68(13):1002&#x2013;1007. doi: 10.1212/01.wnl.0000258551.96893.6f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000258551.96893.6f</ArticleId><ArticleId IdType="pubmed">17389304</ArticleId></ArticleIdList></Reference><Reference><Citation>del Aguila MA, Longstreth WT, Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60(5):813&#x2013;819. doi: 10.1212/01.WNL.0000049472.47709.3B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000049472.47709.3B</ArticleId><ArticleId IdType="pubmed">12629239</ArticleId></ArticleIdList></Reference><Reference><Citation>Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(4):208&#x2013;212. doi: 10.1080/14660820410021311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820410021311</ArticleId><ArticleId IdType="pubmed">15799548</ArticleId></ArticleIdList></Reference><Reference><Citation>Palese F, Sartori A, Logroscino G, Pisa FE. Predictors of diagnostic delay in amyotrophic lateral sclerosis: a cohort study based on administrative and electronic medical records data. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(3-4):176&#x2013;185. doi: 10.1080/21678421.2018.1550517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550517</ArticleId><ArticleId IdType="pubmed">30656971</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin M, Ryan P, Maguire S, Heverin M, Madden C, Vajda A, et al. The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: a population- based study of consultations, interventions and costs. PLoS One. 2017;12(6):e0179796. doi: 10.1371/journal.pone.0179796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179796</ArticleId><ArticleId IdType="pmc">PMC5480998</ArticleId><ArticleId IdType="pubmed">28640860</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards D, Morren JA, Pioro EP. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J Neurol Sci. 2020;417:117054. doi: 10.1016/j.jns.2020.117054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117054</ArticleId><ArticleId IdType="pubmed">32763509</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron D El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsultan AA, Waller R, Heath PR, Kirby J. The genetics of amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis. 2016;6:49&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053097</ArticleId><ArticleId IdType="pubmed">30050368</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Sayana P, Zhang X, Le W. Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener. 2013;8:28. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21(17):3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann EP, Henden L, Fifita JA, Zhang KY, Grima N, Bauer DC, et al. Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis. J Med Genet. 2020. 10.1136/jmedgenet-2020-106866.</Citation><ArticleIdList><ArticleId IdType="pubmed">32409511</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, Ye W, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81(12):1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S, Noyce AJ, Hemani G, Nicolas A, Calvo A, Mora G, et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol. 2019;85(4):470&#x2013;481. doi: 10.1002/ana.25431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, Doherty MA, Davis N, Corr EM, Vajda A, et al. Determining the incidence of familiality in ALS: a study of temporal trends in Ireland from 1994 to 2016. Neurol Genet. 2018;4(3):e239. doi: 10.1212/NXG.0000000000000239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000239</ArticleId><ArticleId IdType="pmc">PMC5961194</ArticleId><ArticleId IdType="pubmed">29845113</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Lewis CM. Modelling the effects of penetrance and family size on rates of sporadic and familial disease. Hum Hered. 2011;71(4):281&#x2013;288. doi: 10.1159/000330167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000330167</ArticleId><ArticleId IdType="pubmed">21846995</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DB, Floate DA, Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci. 1988;86(2-3):215&#x2013;230. doi: 10.1016/0022-510X(88)90100-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(88)90100-1</ArticleId><ArticleId IdType="pubmed">3221241</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones CT, Swingler RJ, Brock DJ. Identification of a novel SOD1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of Ile113Thr in three others. Hum Mol Genet. 1994;3(4):649&#x2013;650. doi: 10.1093/hmg/3.4.649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/3.4.649</ArticleId><ArticleId IdType="pubmed">8069312</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Roses AD, Akkari PA, Chiba-Falek O, Lutz MW, Gottschalk WK, Saunders AM, et al. Structural variants can be more informative for disease diagnostics, prognostics and translation than current SNP mapping and exon sequencing. Expert Opin Drug Metab Toxicol. 2016;12(2):135&#x2013;147. doi: 10.1517/17425255.2016.1133586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17425255.2016.1133586</ArticleId><ArticleId IdType="pubmed">26727306</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323(5918):1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol. 2008;63(4):535&#x2013;538. doi: 10.1002/ana.21344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21344</ArticleId><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, Hardiman O, Al-Chalabi A, Chi&#xf3; A, Savelieff MG, Kiernan MC, et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21(5):465&#x2013;479. doi: 10.1016/S1474-4422(21)00414-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00414-2</ArticleId><ArticleId IdType="pmc">PMC9513754</ArticleId><ArticleId IdType="pubmed">35334234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29(2):166&#x2013;173. doi: 10.1038/ng1001-166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-166</ArticleId><ArticleId IdType="pubmed">11586298</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J, Paul P, Chen HJ, Morris A, Payling M, Falchi M, et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc Natl Acad Sci U S A. 2010;107(16):7556&#x2013;7561. doi: 10.1073/pnas.0914128107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0914128107</ArticleId><ArticleId IdType="pmc">PMC2867752</ArticleId><ArticleId IdType="pubmed">20368421</ArticleId></ArticleIdList></Reference><Reference><Citation>Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, et al. Mutant dynactin in motor neuron disease. Nat Genet. 2003;33(4):455&#x2013;456. doi: 10.1038/ng1123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1123</ArticleId><ArticleId IdType="pubmed">12627231</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, Fukuda Y, Yoshimura J, Toyoda A, Kurppa K, Moritoyo H, et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am J Hum Genet. 2013;93(5):900&#x2013;905. doi: 10.1016/j.ajhg.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.09.008</ArticleId><ArticleId IdType="pmc">PMC3824132</ArticleId><ArticleId IdType="pubmed">24119685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323(5918):1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Moll T, Ramesh T, Castelli L, Beer A, Robins H, et al. Mutations in the glycosyltransferase domain of GLT8D1 are associated with familial amyotrophic lateral sclerosis. Cell Rep. 2019;26(9):2298&#x2013;306.e5. doi: 10.1016/j.celrep.2019.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.02.006</ArticleId><ArticleId IdType="pmc">PMC7003067</ArticleId><ArticleId IdType="pubmed">30811981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495(7442):467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci. 2014;17(5):664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YZ, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4) Am J Hum Genet. 2004;74(6):1128&#x2013;1135. doi: 10.1086/421054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H, Zhou S, Noreau A, Sabbagh M, Belzil V, Dionne-Laporte A, et al. Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol Aging. 2012;33(4):839.e5&#x2013;839.e9. doi: 10.1016/j.neurobiolaging.2011.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.11.012</ArticleId><ArticleId IdType="pubmed">22154821</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133(Pt 2):591&#x2013;598. doi: 10.1093/brain/awp325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp325</ArticleId><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319(5870):1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40(5):572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477(7363):211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, Cascio D, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004;75(5):822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, et al. ANG mutations segregate with familial and &#x2018;sporadic&#x2019; amyotrophic lateral sclerosis. Nat Genet. 2006;38(4):411&#x2013;413. doi: 10.1038/ng1742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1742</ArticleId><ArticleId IdType="pubmed">16501576</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466(7310):1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) Neurology. 2006;67(6):1074&#x2013;1077. doi: 10.1212/01.wnl.0000231510.89311.8b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000231510.89311.8b</ArticleId><ArticleId IdType="pubmed">16807408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatelli M, Eusebi F, Al-Chalabi A, Conte A, Madia F, Luigetti M, et al. Rare missense variants of neuronal nicotinic acetylcholine receptor altering receptor function are associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2009;18(20):3997&#x2013;4006. doi: 10.1093/hmg/ddp339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp339</ArticleId><ArticleId IdType="pubmed">19628475</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, Hart MP, Erion R, King OD, Diaz Z, Nakaya T, et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21(13):2899&#x2013;2911. doi: 10.1093/hmg/dds116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds116</ArticleId><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow CY, Landers JE, Bergren SK, Sapp PC, Grant AE, Jones JM, et al. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet. 2009;84(1):85&#x2013;88. doi: 10.1016/j.ajhg.2008.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.12.010</ArticleId><ArticleId IdType="pmc">PMC2668033</ArticleId><ArticleId IdType="pubmed">19118816</ArticleId></ArticleIdList></Reference><Reference><Citation>Aditi GL, Dawson TR, Wente SR. An amyotrophic lateral sclerosis-linked mutation in GLE1 alters the cellular pool of human Gle1 functional isoforms. Adv Biol Regul. 2016;62:25&#x2013;36. doi: 10.1016/j.jbior.2015.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2015.11.001</ArticleId><ArticleId IdType="pmc">PMC4864155</ArticleId><ArticleId IdType="pubmed">26776475</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, et al. Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum Mol Genet. 1999;8(2):157&#x2013;164. doi: 10.1093/hmg/8.2.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/8.2.157</ArticleId><ArticleId IdType="pubmed">9931323</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, Cronin S, Slowik A, Kasperaviciute D, Van Es MA, Morahan JM, et al. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology. 2009;73(1):16&#x2013;24. doi: 10.1212/WNL.0b013e3181a18674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a18674</ArticleId><ArticleId IdType="pmc">PMC2707108</ArticleId><ArticleId IdType="pubmed">19321847</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung CL, He CZ, Kaufmann P, Chin SS, Naini A, Liem RK, et al. A pathogenic peripherin gene mutation in a patient with amyotrophic lateral sclerosis. Brain Pathol. 2004;14(3):290&#x2013;296. doi: 10.1111/j.1750-3639.2004.tb00066.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2004.tb00066.x</ArticleId><ArticleId IdType="pmc">PMC8095763</ArticleId><ArticleId IdType="pubmed">15446584</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(11):1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, Hart MP, Shorter J, DeJesus-Hernandez M, Erion R, Oristano R, et al. A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A. 2011;108(52):20881&#x2013;20890. doi: 10.1073/pnas.1109434108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109434108</ArticleId><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I, Lin K, Tiloca C, Rooney J, Gellera C, Diekstra FP, et al. Association of a Locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis. JAMA Neurol. 2016;73(7):812&#x2013;820. doi: 10.1001/jamaneurol.2016.1114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.1114</ArticleId><ArticleId IdType="pmc">PMC5556366</ArticleId><ArticleId IdType="pubmed">27244217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97(6):1268&#x2013;83 e6. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Tazelaar GHP, Dekker AM, van Vugt J, van der Spek RA, Westeneng HJ, Kool L, et al. Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort. Neurobiol Aging. 2019;74:234.e9&#x2013;234e15. doi: 10.1016/j.neurobiolaging.2018.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.09.012</ArticleId><ArticleId IdType="pmc">PMC7893598</ArticleId><ArticleId IdType="pubmed">30342764</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilley J, Jackson O, Pipis M, Estiar MA, Al-Chalabi A, Danzi MC, et al. Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders. Elife. 2021;10:e70905. doi: 10.7554/eLife.70905.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.70905</ArticleId><ArticleId IdType="pmc">PMC8735862</ArticleId><ArticleId IdType="pubmed">34796871</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95(4):808&#x2013;16 e9. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra FP, van Vught PW, van Rheenen W, Koppers M, Pasterkamp RJ, van Es MA, et al. UNC13A is a modifier of survival in amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(3):630.e3&#x2013;630.e8. doi: 10.1016/j.neurobiolaging.2011.10.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.10.029</ArticleId><ArticleId IdType="pubmed">22118904</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Mora G, Restagno G, Brunetti M, Ossola I, Barberis M, et al. UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study. Neurobiol Aging. 2013;34(1):357.e1&#x2013;357.e5. doi: 10.1016/j.neurobiolaging.2012.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.07.016</ArticleId><ArticleId IdType="pmc">PMC3483408</ArticleId><ArticleId IdType="pubmed">22921269</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, Topp SD, Fallini C, Shibata H, Chen HJ, Troakes C, et al. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci Transl Med. 2017;9(388):eaad9157. doi: 10.1126/scitranslmed.aad9157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aad9157</ArticleId><ArticleId IdType="pmc">PMC6599403</ArticleId><ArticleId IdType="pubmed">28469040</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137(Pt 8):2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaussenot A, Le Ber I, Ait-El-Mkadem S, Camuzat A, de Septenville A, Bannwarth S, et al. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients. Neurobiol Aging. 2014;35(12):2884.e1&#x2013;2884.e4. doi: 10.1016/j.neurobiolaging.2014.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.022</ArticleId><ArticleId IdType="pubmed">25155093</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan SMK, Howrigan DP, Abbott LE, Klim JR, Topp SD, Byrnes AE, et al. Publisher correction: exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat Neurosci. 2020;23(2):295. doi: 10.1038/s41593-019-0570-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0570-5</ArticleId><ArticleId IdType="pubmed">31857710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, van Doormaal PT, Dekker AM, Ticozzi N, Kenna BJ, Diekstra FP, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1037&#x2013;1042. doi: 10.1038/ng.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Muller K, Wieland T, Weydt P, Bohm S, Lule D, et al. NEK1 mutations in familial amyotrophic lateral sclerosis. Brain. 2016;139(Pt 5):e28. doi: 10.1093/brain/aww033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww033</ArticleId><ArticleId IdType="pubmed">26945885</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Mossevelde S, Dillen L, De Bleecker JL, Moisse M, Van Damme P, et al. NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients. Neurobiol Aging. 2018;61:255.e1&#x2013;255.e7. doi: 10.1016/j.neurobiolaging.2017.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.08.021</ArticleId><ArticleId IdType="pubmed">28935222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu S, Lei X, Liu F, Cui B, Liu Q, Ding Q, et al. Mutation screening of NEK1 in Chinese ALS patients. Neurobiol Aging. 2018;71:267.e1&#x2013;267.e4. doi: 10.1016/j.neurobiolaging.2018.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.022</ArticleId><ArticleId IdType="pubmed">30093141</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CH, Fallini C, Ticozzi N, Keagle PJ, Sapp PC, Piotrowska K, et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488(7412):499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347(6229):1436&#x2013;1441. doi: 10.1126/science.aaa3650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G, Pugliatti M, Marrosu F, Marrosu MG, Murru MR, Floris G, et al. TBK1 is associated with ALS and ALS-FTD in Sardinian patients. Neurobiol Aging. 2016;43:180.e1&#x2013;180.e5. doi: 10.1016/j.neurobiolaging.2016.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.03.028</ArticleId><ArticleId IdType="pmc">PMC8961272</ArticleId><ArticleId IdType="pubmed">27156075</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes JA, Davies MC, Collins MO. TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain. 2017;10(1):5. doi: 10.1186/s13041-017-0287-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0287-x</ArticleId><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp S, Kenna KP, et al. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron. 2014;84(2):324&#x2013;331. doi: 10.1016/j.neuron.2014.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.027</ArticleId><ArticleId IdType="pmc">PMC4521390</ArticleId><ArticleId IdType="pubmed">25374358</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato V, Tiloca C, Corrado L, Bertolin C, Sardone V, Del Bo R, et al. TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations. J Neurol. 2015;262(5):1376&#x2013;1378. doi: 10.1007/s00415-015-7739-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7739-y</ArticleId><ArticleId IdType="pmc">PMC6614739</ArticleId><ArticleId IdType="pubmed">25893256</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5):857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A, Bohlega S, Al-Mohanna F. Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. Ann Neurol. 2012;72(4):510&#x2013;516. doi: 10.1002/ana.23641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23641</ArticleId><ArticleId IdType="pubmed">23109145</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats KA, Laird AS, et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med. 2012;18(9):1418&#x2013;1422. doi: 10.1038/nm.2901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2901</ArticleId><ArticleId IdType="pubmed">22922411</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465(7295):223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambrechts D, Poesen K, Fernandez-Santiago R, Al-Chalabi A, Del Bo R, Van Vught PW, et al. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. J Med Genet. 2009;46(12):840&#x2013;846. doi: 10.1136/jmg.2008.058222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2008.058222</ArticleId><ArticleId IdType="pubmed">18413368</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, Sreedharan J, et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain. 2006;129(Pt 4):868&#x2013;876. doi: 10.1093/brain/awl030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl030</ArticleId><ArticleId IdType="pubmed">16495328</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson JP, Williams NM, Majounie E, Waite A, Stott J, Newsway V, et al. Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p. J Neurol. 2011;258(4):647&#x2013;655. doi: 10.1007/s00415-010-5815-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5815-x</ArticleId><ArticleId IdType="pmc">PMC4696389</ArticleId><ArticleId IdType="pubmed">21072532</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology. 2006;66(6):839&#x2013;844. doi: 10.1212/01.wnl.0000200048.53766.b4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000200048.53766.b4</ArticleId><ArticleId IdType="pubmed">16421333</ArticleId></ArticleIdList></Reference><Reference><Citation>Boxer AL, Mackenzie IR, Boeve BF, Baker M, Seeley WW, Crook R, et al. Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry. 2011;82(2):196&#x2013;203. doi: 10.1136/jnnp.2009.204081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.204081</ArticleId><ArticleId IdType="pmc">PMC3017222</ArticleId><ArticleId IdType="pubmed">20562461</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok K, Traynor BJ, Schymick J, Tienari PJ, Laaksovirta H, Peuralinna T, et al. Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging. 2012;33(1):209.e3&#x2013;209.e8. doi: 10.1016/j.neurobiolaging.2011.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.08.005</ArticleId><ArticleId IdType="pmc">PMC3312749</ArticleId><ArticleId IdType="pubmed">21925771</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet. 2009;41(10):1083&#x2013;1087. doi: 10.1038/ng.442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.442</ArticleId><ArticleId IdType="pubmed">19734901</ArticleId></ArticleIdList></Reference><Reference><Citation>Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai SL, Myllykangas L, et al. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol. 2010;9(10):978&#x2013;985. doi: 10.1016/S1474-4422(10)70184-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70184-8</ArticleId><ArticleId IdType="pmc">PMC2965392</ArticleId><ArticleId IdType="pubmed">20801718</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, Vance C, et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol. 2010;9(10):986&#x2013;994. doi: 10.1016/S1474-4422(10)70197-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70197-6</ArticleId><ArticleId IdType="pmc">PMC3257853</ArticleId><ArticleId IdType="pubmed">20801717</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42(3):234&#x2013;239. doi: 10.1038/ng.536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.536</ArticleId><ArticleId IdType="pmc">PMC2828525</ArticleId><ArticleId IdType="pubmed">20154673</ArticleId></ArticleIdList></Reference><Reference><Citation>International HapMap C. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449(7164):851&#x2013;861. doi: 10.1038/nature06258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06258</ArticleId><ArticleId IdType="pmc">PMC2689609</ArticleId><ArticleId IdType="pubmed">17943122</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin RL, Vajda A, Hardiman O. Heritability of amyotrophic lateral sclerosis: insights from disparate numbers. JAMA Neurol. 2015;72(8):857&#x2013;858. doi: 10.1001/jamaneurol.2014.4049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.4049</ArticleId><ArticleId IdType="pubmed">26029874</ArticleId></ArticleIdList></Reference><Reference><Citation>Luigetti M, Lattante S, Zollino M, Conte A, Marangi G, Del Grande A, et al. SOD1 G93D sporadic amyotrophic lateral sclerosis (SALS) patient with rapid progression and concomitant novel ANG variant. Neurobiol Aging. 2011;32(10):1924.e15&#x2013;1924.e18. doi: 10.1016/j.neurobiolaging.2011.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.04.004</ArticleId><ArticleId IdType="pubmed">21621297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamp M, Origone P, Geroldi A, Verdiani S, Gotta F, Caponnetto C, et al. Twenty years of molecular analyses in amyotrophic lateral sclerosis: genetic landscape of Italian patients. Neurobiol Aging. 2018;66:179.e5&#x2013;179e16. doi: 10.1016/j.neurobiolaging.2018.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.01.013</ArticleId><ArticleId IdType="pubmed">29525178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Tang H. Next-generation sequencing technologies and fragment assembly algorithms. Methods Mol Biol. 2012;855:155&#x2013;174. doi: 10.1007/978-1-61779-582-4_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-582-4_5</ArticleId><ArticleId IdType="pubmed">22407708</ArticleId></ArticleIdList></Reference><Reference><Citation>Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM. Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol. 2007;8(7):R143. doi: 10.1186/gb-2007-8-7-r143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2007-8-7-r143</ArticleId><ArticleId IdType="pmc">PMC2323236</ArticleId><ArticleId IdType="pubmed">17659080</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentley DR. Whole-genome re-sequencing. Curr Opin Genet Dev. 2006;16(6):545&#x2013;552. doi: 10.1016/j.gde.2006.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2006.10.009</ArticleId><ArticleId IdType="pubmed">17055251</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolzhenko E, van Vugt J, Shaw RJ, Bekritsky MA, van Blitterswijk M, Narzisi G, et al. Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Res. 2017;27(11):1895&#x2013;1903. doi: 10.1101/gr.225672.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.225672.117</ArticleId><ArticleId IdType="pmc">PMC5668946</ArticleId><ArticleId IdType="pubmed">28887402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionita-Laza I, McCallum K, Xu B, Buxbaum JD. A spectral approach integrating functional genomic annotations for coding and noncoding variants. Nat Genet. 2016;48(2):214&#x2013;220. doi: 10.1038/ng.3477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3477</ArticleId><ArticleId IdType="pmc">PMC4731313</ArticleId><ArticleId IdType="pubmed">26727659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99(4):877&#x2013;885. doi: 10.1016/j.ajhg.2016.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.08.016</ArticleId><ArticleId IdType="pmc">PMC5065685</ArticleId><ArticleId IdType="pubmed">27666373</ArticleId></ArticleIdList></Reference><Reference><Citation>Listgarten J, Lippert C, Heckerman D. FaST-LMM-select for addressing confounding from spatial structure and rare variants. Nat Genet. 2013;45(5):470&#x2013;471. doi: 10.1038/ng.2620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2620</ArticleId><ArticleId IdType="pubmed">23619783</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Muller K, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18(5):631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, van der Spek RAA, Bakker MK, van Vugt J, Hop PJ, Zwamborn RAJ, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53(12):1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Khleifat A, Iacoangeli A, van Vugt J, Bowles H, Moisse M, Zwamborn RAJ, et al. Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis. NPJ Genom Med. 2022;7(1):8. doi: 10.1038/s41525-021-00267-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-021-00267-9</ArticleId><ArticleId IdType="pmc">PMC8799638</ArticleId><ArticleId IdType="pubmed">35091648</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebbert MTW, Farrugia SL, Sens JP, Jansen-West K, Gendron TF, Prudencio M, et al. Long-read sequencing across the C9orf72 'GGGGCC' repeat expansion: implications for clinical use and genetic discovery efforts in human disease. Mol Neurodegener. 2018;13(1):46. doi: 10.1186/s13024-018-0274-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0274-4</ArticleId><ArticleId IdType="pmc">PMC6102925</ArticleId><ArticleId IdType="pubmed">30126445</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron DL, Di Stefano L, Papenfuss AT. Comprehensive evaluation and characterisation of short read general-purpose structural variant calling software. Nat Commun. 2019;10(1):3240. doi: 10.1038/s41467-019-11146-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11146-4</ArticleId><ArticleId IdType="pmc">PMC6642177</ArticleId><ArticleId IdType="pubmed">31324872</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi N, Shleizer-Burko S, Yanicky R, Gymrek M. Profiling the genome-wide landscape of tandem repeat expansions. Nucleic Acids Res. 2019;47(15):e90. doi: 10.1093/nar/gkz501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz501</ArticleId><ArticleId IdType="pmc">PMC6735967</ArticleId><ArticleId IdType="pubmed">31194863</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems T, Zielinski D, Yuan J, Gordon A, Gymrek M, Erlich Y. Genome-wide profiling of heritable and de novo STR variations. Nat Methods. 2017;14(6):590&#x2013;592. doi: 10.1038/nmeth.4267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4267</ArticleId><ArticleId IdType="pmc">PMC5482724</ArticleId><ArticleId IdType="pubmed">28436466</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen F, Flynn LL, Anderton RS, Mastaglia F, Pytte J, Jiang L, et al. Structural variants may be a source of missing heritability in sALS. Front Neurosci. 2020;14:47. doi: 10.3389/fnins.2020.00047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00047</ArticleId><ArticleId IdType="pmc">PMC7005198</ArticleId><ArticleId IdType="pubmed">32082115</ArticleId></ArticleIdList></Reference><Reference><Citation>Eid J, Fehr A, Gray J, Luong K, Lyle J, Otto G, et al. Real-time DNA sequencing from single polymerase molecules. Science. 2009;323(5910):133&#x2013;138. doi: 10.1126/science.1162986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1162986</ArticleId><ArticleId IdType="pubmed">19023044</ArticleId></ArticleIdList></Reference><Reference><Citation>Levene MJ, Korlach J, Turner SW, Foquet M, Craighead HG, Webb WW. Zero-mode waveguides for single-molecule analysis at high concentrations. Science. 2003;299(5607):682&#x2013;686. doi: 10.1126/science.1079700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1079700</ArticleId><ArticleId IdType="pubmed">12560545</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain M, Olsen HE, Paten B, Akeson M. The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community. Genome Biol. 2016;17(1):239. doi: 10.1186/s13059-016-1103-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-016-1103-0</ArticleId><ArticleId IdType="pmc">PMC5124260</ArticleId><ArticleId IdType="pubmed">27887629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain M, Fiddes IT, Miga KH, Olsen HE, Paten B, Akeson M. Improved data analysis for the MinION nanopore sequencer. Nat Methods. 2015;12(4):351&#x2013;356. doi: 10.1038/nmeth.3290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3290</ArticleId><ArticleId IdType="pmc">PMC4907500</ArticleId><ArticleId IdType="pubmed">25686389</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro MO, Russ C, Ross MG, Gabriel SB, Nusbaum C, DePristo MA. Pacific biosciences sequencing technology for genotyping and variation discovery in human data. BMC Genomics. 2012;13:375. doi: 10.1186/1471-2164-13-375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-13-375</ArticleId><ArticleId IdType="pmc">PMC3443046</ArticleId><ArticleId IdType="pubmed">22863213</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts RJ, Carneiro MO, Schatz MC. The advantages of SMRT sequencing. Genome Biol. 2013;14(7):405. doi: 10.1186/gb-2013-14-6-405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2013-14-6-405</ArticleId><ArticleId IdType="pmc">PMC3953343</ArticleId><ArticleId IdType="pubmed">23822731</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenger AM, Peluso P, Rowell WJ, Chang PC, Hall RJ, Concepcion GT, et al. Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome. Nat Biotechnol. 2019;37(10):1155&#x2013;1162. doi: 10.1038/s41587-019-0217-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0217-9</ArticleId><ArticleId IdType="pmc">PMC6776680</ArticleId><ArticleId IdType="pubmed">31406327</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacific Biosciences- Revio. Available from: https://www.pacb.com/revio/. Accessed 23 Nov 2022.</Citation></Reference><Reference><Citation>Jain M, Koren S, Miga KH, Quick J, Rand AC, Sasani TA, et al. Nanopore sequencing and assembly of a human genome with ultra-long reads. Nat Biotechnol. 2018;36(4):338&#x2013;345. doi: 10.1038/nbt.4060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.4060</ArticleId><ArticleId IdType="pmc">PMC5889714</ArticleId><ArticleId IdType="pubmed">29431738</ArticleId></ArticleIdList></Reference><Reference><Citation>Deamer D, Akeson M, Branton D. Three decades of nanopore sequencing. Nat Biotechnol. 2016;34(5):518&#x2013;524. doi: 10.1038/nbt.3423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3423</ArticleId><ArticleId IdType="pmc">PMC6733523</ArticleId><ArticleId IdType="pubmed">27153285</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lannoy C, de Ridder D, Risse J. The long reads ahead: de novo genome assembly using the MinION. F1000Res. 2017;6:1083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5770995</ArticleId><ArticleId IdType="pubmed">29375809</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden R, Davies RW, Heger A, Pagnamenta AT, de Cesare M, Oikkonen LE, et al. Sequencing of human genomes with nanopore technology. Nat Commun. 2019;10(1):1869. doi: 10.1038/s41467-019-09637-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09637-5</ArticleId><ArticleId IdType="pmc">PMC6478738</ArticleId><ArticleId IdType="pubmed">31015479</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxford Nanopore Technologies - MinIon. https://nanoporetech.com/products/minion. Accessed 26 Sept 2022.</Citation></Reference><Reference><Citation>Payne A, Holmes N, Rakyan V, Loose M. BulkVis: a graphical viewer for Oxford nanopore bulk FAST5 files. Bioinformatics. 2019;35(13):2193&#x2013;2198. doi: 10.1093/bioinformatics/bty841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty841</ArticleId><ArticleId IdType="pmc">PMC6596899</ArticleId><ArticleId IdType="pubmed">30462145</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxford Nanopore Technologies - GridION. Available from: https://nanoporetech.com/products/gridion. Cited 2022 26 September.</Citation></Reference><Reference><Citation>Kim HS, Jeon S, Kim C, Kim YK, Cho YS, Kim J, et al. Chromosome-scale assembly comparison of the Korean Reference Genome KOREF from PromethION and PacBio with Hi-C mapping information. Gigascience. 2019;8(12):giz125. doi: 10.1093/gigascience/giz125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gigascience/giz125</ArticleId><ArticleId IdType="pmc">PMC6889754</ArticleId><ArticleId IdType="pubmed">31794015</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxford Nanopore Technologies &#x2013; PromethION. Available from: https://nanoporetech.com/products/promethion. Cited 2022 26 September.</Citation></Reference><Reference><Citation>Rang FJ, Kloosterman WP, de Ridder J. From squiggle to basepair: computational approaches for improving nanopore sequencing read accuracy. Genome Biol. 2018;19(1):90. doi: 10.1186/s13059-018-1462-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-018-1462-9</ArticleId><ArticleId IdType="pmc">PMC6045860</ArticleId><ArticleId IdType="pubmed">30005597</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxford Nanopore Technologies- Accuracy of reads. Available from: https://nanoporetech.com/accuracy. Cited 2022 26 September.</Citation></Reference><Reference><Citation>Wang B, Tseng E, Regulski M, Clark TA, Hon T, Jiao Y, et al. Unveiling the complexity of the maize transcriptome by single-molecule long-read sequencing. Nat Commun. 2016;7:11708. doi: 10.1038/ncomms11708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11708</ArticleId><ArticleId IdType="pmc">PMC4931018</ArticleId><ArticleId IdType="pubmed">27339440</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin K, Koren S, Chin CS, Drake JP, Landolin JM, Phillippy AM. Assembling large genomes with single-molecule sequencing and locality-sensitive hashing. Nat Biotechnol. 2015;33(6):623&#x2013;630. doi: 10.1038/nbt.3238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3238</ArticleId><ArticleId IdType="pubmed">26006009</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt MH, Vogel A, Denton AK, Istace B, Wormit A, van de Geest H, et al. De novo assembly of a new Solanum pennellii accession using nanopore sequencing. Plant Cell. 2017;29(10):2336&#x2013;2348. doi: 10.1105/tpc.17.00521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1105/tpc.17.00521</ArticleId><ArticleId IdType="pmc">PMC5774570</ArticleId><ArticleId IdType="pubmed">29025960</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L, Guo Y, Dong C, Huddleston J, Yang H, Han X, et al. Long-read sequencing and de novo assembly of a Chinese genome. Nat Commun. 2016;7:12065. doi: 10.1038/ncomms12065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12065</ArticleId><ArticleId IdType="pmc">PMC4931320</ArticleId><ArticleId IdType="pubmed">27356984</ArticleId></ArticleIdList></Reference><Reference><Citation>Miga KH, Koren S, Rhie A, Vollger MR, Gershman A, Bzikadze A, et al. Telomere-to-telomere assembly of a complete human X chromosome. Nature. 2020;585(7823):79&#x2013;84. doi: 10.1038/s41586-020-2547-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2547-7</ArticleId><ArticleId IdType="pmc">PMC7484160</ArticleId><ArticleId IdType="pubmed">32663838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al. The complete sequence of a human genome. Science. 2022;376(6588):44&#x2013;53. doi: 10.1126/science.abj6987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj6987</ArticleId><ArticleId IdType="pmc">PMC9186530</ArticleId><ArticleId IdType="pubmed">35357919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaisson MJ, Huddleston J, Dennis MY, Sudmant PH, Malig M, Hormozdiari F, et al. Resolving the complexity of the human genome using single-molecule sequencing. Nature. 2015;517(7536):608&#x2013;611. doi: 10.1038/nature13907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13907</ArticleId><ArticleId IdType="pmc">PMC4317254</ArticleId><ArticleId IdType="pubmed">25383537</ArticleId></ArticleIdList></Reference><Reference><Citation>Huddleston J, Chaisson MJP, Steinberg KM, Warren W, Hoekzema K, Gordon D, et al. Discovery and genotyping of structural variation from long-read haploid genome sequence data. Genome Res. 2017;27(5):677&#x2013;685. doi: 10.1101/gr.214007.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.214007.116</ArticleId><ArticleId IdType="pmc">PMC5411763</ArticleId><ArticleId IdType="pubmed">27895111</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaisson MJP, Sanders AD, Zhao X, Malhotra A, Porubsky D, Rausch T, et al. Multi-platform discovery of haplotype-resolved structural variation in human genomes. Nat Commun. 2019;10(1):1784. doi: 10.1038/s41467-018-08148-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-08148-z</ArticleId><ArticleId IdType="pmc">PMC6467913</ArticleId><ArticleId IdType="pubmed">30992455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert P, Audano PA, Zhu Q, Rodriguez-Martin B, Porubsky D, Bonder MJ, et al. Haplotype-resolved diverse human genomes and integrated analysis of structural variation. Science. 2021;372(6537):eabf7117. doi: 10.1126/science.abf7117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf7117</ArticleId><ArticleId IdType="pmc">PMC8026704</ArticleId><ArticleId IdType="pubmed">33632895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebbert MTW, Jensen TD, Jansen-West K, Sens JP, Reddy JS, Ridge PG, et al. Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight. Genome Biol. 2019;20(1):97. doi: 10.1186/s13059-019-1707-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-019-1707-2</ArticleId><ArticleId IdType="pmc">PMC6526621</ArticleId><ArticleId IdType="pubmed">31104630</ArticleId></ArticleIdList></Reference><Reference><Citation>Merker JD, Wenger AM, Sneddon T, Grove M, Zappala Z, Fresard L, et al. Long-read genome sequencing identifies causal structural variation in a Mendelian disease. Genet Med. 2018;20(1):159&#x2013;163. doi: 10.1038/gim.2017.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2017.86</ArticleId><ArticleId IdType="pmc">PMC5741540</ArticleId><ArticleId IdType="pubmed">28640241</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta UR, Rao SN, Pidugu VK, Vineeth VS, Bhattacherjee A, Bhowmik AD, et al. Breakpoint mapping of a novel de novo translocation t(X;20)(q11.1;p13) by positional cloning and long read sequencing. Genomics. 2019;111(5):1108&#x2013;1114. doi: 10.1016/j.ygeno.2018.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2018.07.005</ArticleId><ArticleId IdType="pubmed">30006036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiura H, Doi K, Mitsui J, Yoshimura J, Matsukawa MK, Fujiyama A, et al. Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy. Nat Genet. 2018;50(4):581&#x2013;590. doi: 10.1038/s41588-018-0067-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0067-2</ArticleId><ArticleId IdType="pubmed">29507423</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng S, Zhang MY, Wang XJ, Hu ZM, Li JC, Li N, et al. Long-read sequencing identified intronic repeat expansions in SAMD12 from Chinese pedigrees affected with familial cortical myoclonic tremor with epilepsy. J Med Genet. 2019;56(4):265&#x2013;270. doi: 10.1136/jmedgenet-2018-105484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2018-105484</ArticleId><ArticleId IdType="pubmed">30194086</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuguchi T, Suzuki T, Abe C, Umemura A, Tokunaga K, Kawai Y, et al. A 12-kb structural variation in progressive myoclonic epilepsy was newly identified by long-read whole-genome sequencing. J Hum Genet. 2019;64(5):359&#x2013;368. doi: 10.1038/s10038-019-0569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s10038-019-0569-5</ArticleId><ArticleId IdType="pubmed">30760880</ArticleId></ArticleIdList></Reference><Reference><Citation>Vialle RA, de Paiva Lopes K, Bennett DA, Crary JF, Raj T. Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain. Nat Neurosci. 2022;25(4):504&#x2013;514. doi: 10.1038/s41593-022-01031-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-022-01031-7</ArticleId><ArticleId IdType="pmc">PMC9245608</ArticleId><ArticleId IdType="pubmed">35288716</ArticleId></ArticleIdList></Reference><Reference><Citation>Yau WY, Vandrovcova J, Sullivan R, Chen Z, Zecchinelli A, Cilia R, et al. Low prevalence of NOTCH2NLC GGC repeat expansion in white patients with movement disorders. Mov Disord. 2021;36(1):251&#x2013;255. doi: 10.1002/mds.28302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28302</ArticleId><ArticleId IdType="pmc">PMC8436747</ArticleId><ArticleId IdType="pubmed">33026126</ArticleId></ArticleIdList></Reference><Reference><Citation>Loomis EW, Eid JS, Peluso P, Yin J, Hickey L, Rank D, et al. Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X gene. Genome Res. 2013;23(1):121&#x2013;128. doi: 10.1101/gr.141705.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.141705.112</ArticleId><ArticleId IdType="pmc">PMC3530672</ArticleId><ArticleId IdType="pubmed">23064752</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardui S, Race V, de Ravel T, Van Esch H, Devriendt K, Matthijs G, et al. Detecting AGG interruptions in females with a FMR1 premutation by long-read single-molecule sequencing: a 1 year clinical experience. Front Genet. 2018;9:150. doi: 10.3389/fgene.2018.00150.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00150</ArticleId><ArticleId IdType="pmc">PMC5964127</ArticleId><ArticleId IdType="pubmed">29868108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Wang JL, Huang W, Zeng S, Jiao B, Liu Z, et al. Expansion of human-specific GGC repeat in neuronal Intranuclear inclusion disease-related disorders. Am J Hum Genet. 2019;105(1):166&#x2013;176. doi: 10.1016/j.ajhg.2019.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2019.05.013</ArticleId><ArticleId IdType="pmc">PMC6612530</ArticleId><ArticleId IdType="pubmed">31178126</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai YC, de Pontual L, Heiner C, Stojkovic T, Furling D, Bassez G, et al. Identification of a CCG-enriched expanded allele in DM1 patients using amplification-free long-read sequencing. J Mol Diagn. 2022;24(11):114. doi: 10.1016/j.jmoldx.2022.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmoldx.2022.08.003</ArticleId><ArticleId IdType="pubmed">36084803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoijer I, Tsai YC, Clark TA, Kotturi P, Dahl N, Stattin EL, et al. Detailed analysis of HTT repeat elements in human blood using targeted amplification-free long-read sequencing. Hum Mutat. 2018;39(9):1262&#x2013;1272. doi: 10.1002/humu.23580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23580</ArticleId><ArticleId IdType="pmc">PMC6175010</ArticleId><ArticleId IdType="pubmed">29932473</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacific Biosciences- Targeted sequencing. Available from: https://www.pacb.com/products-and-services/applications/targeted-sequencing/. Cited 2022 26 September.</Citation></Reference><Reference><Citation>DeJesus-Hernandez M, Aleff RA, Jackson JL, Finch NA, Baker MC, Gendron TF, et al. Long-read targeted sequencing uncovers clinicopathological associations for C9orf72-linked diseases. Brain. 2021;144(4):1082&#x2013;1088. doi: 10.1093/brain/awab006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab006</ArticleId><ArticleId IdType="pmc">PMC8105038</ArticleId><ArticleId IdType="pubmed">33889947</ArticleId></ArticleIdList></Reference><Reference><Citation>Course MM, Gudsnuk K, Smukowski SN, Winston K, Desai N, Ross JP, et al. Evolution of a human-specific tandem repeat associated with ALS. Am J Hum Genet. 2020;107(3):445&#x2013;460. doi: 10.1016/j.ajhg.2020.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2020.07.004</ArticleId><ArticleId IdType="pmc">PMC7477013</ArticleId><ArticleId IdType="pubmed">32750315</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y-C, Zafar F, McEachin ZT, McLaughlin I, Blitterswijk M, Ziegle J, et al. Multiplex CRISPR/Cas9-Guided No-Amp targeted sequencing panel for spinocerebellar ataxia repeat expansions. Neuromethods. 2022;182: Springer Nature.</Citation></Reference><Reference><Citation>Morato Torres CA, Zafar F, Tsai YC, Vazquez JP, Gallagher MD, McLaughlin I, et al. ATTCT and ATTCC repeat expansions in the ATXN10 gene affect disease penetrance of spinocerebellar ataxia type 10. HGG Adv. 2022;3(4):100137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9460507</ArticleId><ArticleId IdType="pubmed">36092952</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulst SM, Nechiporuk A, Nechiporuk T, Gispert S, Chen XN, Lopes-Cendes I, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996;14(3):269&#x2013;276. doi: 10.1038/ng1196-269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1196-269</ArticleId><ArticleId IdType="pubmed">8896555</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, et al. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology. 2011;76(24):2066&#x2013;2072. doi: 10.1212/WNL.0b013e31821f445b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821f445b</ArticleId><ArticleId IdType="pubmed">21562247</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, Mullen B, Heckman MG, Baker MC, DeJesus-Hernandez M, Brown PH, et al. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol Aging. 2014;35(10):2421.e13&#x2013;2421.e17. doi: 10.1016/j.neurobiolaging.2014.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.04.016</ArticleId><ArticleId IdType="pmc">PMC4105839</ArticleId><ArticleId IdType="pubmed">24866401</ArticleId></ArticleIdList></Reference><Reference><Citation>Flusberg BA, Webster DR, Lee JH, Travers KJ, Olivares EC, Clark TA, et al. Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat Methods. 2010;7(6):461&#x2013;465. doi: 10.1038/nmeth.1459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1459</ArticleId><ArticleId IdType="pmc">PMC2879396</ArticleId><ArticleId IdType="pubmed">20453866</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszlo AH, Derrington IM, Brinkerhoff H, Langford KW, Nova IC, Samson JM, et al. Detection and mapping of 5-methylcytosine and 5-hydroxymethylcytosine with nanopore MspA. Proc Natl Acad Sci U S A. 2013;110(47):18904&#x2013;18909. doi: 10.1073/pnas.1310240110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1310240110</ArticleId><ArticleId IdType="pmc">PMC3839702</ArticleId><ArticleId IdType="pubmed">24167255</ArticleId></ArticleIdList></Reference><Reference><Citation>Adewale BA. Will long-read sequencing technologies replace short-read sequencing technologies in the next 10 years? Afr J Lab Med. 2020;9(1):1340. doi: 10.4102/ajlm.v9i1.1340.</Citation><ArticleIdList><ArticleId IdType="doi">10.4102/ajlm.v9i1.1340</ArticleId><ArticleId IdType="pmc">PMC7736650</ArticleId><ArticleId IdType="pubmed">33354530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349(6248):650&#x2013;655. doi: 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang PM, Ling J, Jeong YH, Price DL, Aja SM, Wong PC. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci U S A. 2010;107(37):16320&#x2013;16324. doi: 10.1073/pnas.1002176107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002176107</ArticleId><ArticleId IdType="pmc">PMC2941284</ArticleId><ArticleId IdType="pubmed">20660762</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14(4):459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci. 2012;15(11):1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay U, Cotney J, Nagy M, Oh S, Leng J, Mahajan M, et al. RNA-Seq profiling of spinal cord motor neurons from a presymptomatic SOD1 ALS mouse. PLoS One. 2013;8(1):e53575. doi: 10.1371/journal.pone.0053575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0053575</ArticleId><ArticleId IdType="pmc">PMC3536741</ArticleId><ArticleId IdType="pubmed">23301088</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Belzil VV, Batra R, Ross CA, Gendron TF, Pregent LJ, et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci. 2015;18(8):1175&#x2013;1182. doi: 10.1038/nn.4065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Gonzales PK, Cook CN, Gendron TF, Daughrity LM, Song Y, et al. Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients. Hum Mol Genet. 2017;26(17):3421&#x2013;3431. doi: 10.1093/hmg/ddx233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx233</ArticleId><ArticleId IdType="pmc">PMC5886204</ArticleId><ArticleId IdType="pubmed">28637276</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Baker MC, Jackson JL, DeJesus-Hernandez M, Finch NA, Tian S, et al. Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers. Acta Neuropathol Commun. 2019;7(1):150. doi: 10.1186/s40478-019-0797-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0797-0</ArticleId><ArticleId IdType="pmc">PMC6781370</ArticleId><ArticleId IdType="pubmed">31594549</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, et al. Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 2019;29(5):1164&#x2013;77 e5. doi: 10.1016/j.celrep.2019.09.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.09.066</ArticleId><ArticleId IdType="pmc">PMC6866666</ArticleId><ArticleId IdType="pubmed">31665631</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Humphrey J, Pickles S, Brown AL, Hill SE, Kachergus JM, et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J Clin Invest. 2020;130(11):6080&#x2013;6092. doi: 10.1172/JCI139741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139741</ArticleId><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22(2):167&#x2013;179. doi: 10.1038/s41593-018-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, Lopez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019;22(2):180&#x2013;190. doi: 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, et al. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature. 2022;603(7899):124&#x2013;130. doi: 10.1038/s41586-022-04424-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04424-7</ArticleId><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AL, Wilkins OG, Keuss MJ, Hill SE, Zanovello M, Lee WC, et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603(7899):131&#x2013;137. doi: 10.1038/s41586-022-04436-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04436-3</ArticleId><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature. 2019;570(7761):332&#x2013;337. doi: 10.1038/s41586-019-1195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1195-2</ArticleId><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Saez-Atienzar S, Bandres-Ciga S, Langston RG, Kim JJ, Choi SW, Reynolds RH, et al. Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types. Sci Adv. 2021;7(3):eabd9036. doi: 10.1126/sciadv.abd9036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd9036</ArticleId><ArticleId IdType="pmc">PMC7810371</ArticleId><ArticleId IdType="pubmed">33523907</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S, Aijo T, Vickovic S, Braine C, Kang K, Mollbrink A, et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364(6435):89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory JM, McDade K, Livesey MR, Croy I, Marion de Proce S, Aitman T, et al. Spatial transcriptomics identifies spatially dysregulated expression of GRM3 and USP47 in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2020;46(5):441&#x2013;457. doi: 10.1111/nan.12597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12597</ArticleId><ArticleId IdType="pubmed">31925813</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WT, Lu A, Craessaerts K, Pavie B, Sala Frigerio C, Corthout N, et al. Spatial transcriptomics and in situ sequencing to study Alzheimer&#x2019;s disease. Cell. 2020;182(4):976&#x2013;91 e19. doi: 10.1016/j.cell.2020.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.038</ArticleId><ArticleId IdType="pubmed">32702314</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung SK, Jeffries AR, Castanho I, Jordan BT, Moore K, Davies JP, et al. Full-length transcript sequencing of human and mouse cerebral cortex identifies widespread isoform diversity and alternative splicing. Cell Rep. 2021;37(7):110022. doi: 10.1016/j.celrep.2021.110022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110022</ArticleId><ArticleId IdType="pmc">PMC8609283</ArticleId><ArticleId IdType="pubmed">34788620</ArticleId></ArticleIdList></Reference><Reference><Citation>Abston ED, Coronado MJ, Bucek A, Bedja D, Shin J, Kim JB, et al. Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin Dev Immunol. 2012;2012:129486. doi: 10.1155/2012/129486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/129486</ArticleId><ArticleId IdType="pmc">PMC3195533</ArticleId><ArticleId IdType="pubmed">22013485</ArticleId></ArticleIdList></Reference><Reference><Citation>Workman RE, Tang AD, Tang PS, Jain M, Tyson JR, Razaghi R, et al. Nanopore native RNA sequencing of a human poly(A) transcriptome. Nat Methods. 2019;16(12):1297&#x2013;1305. doi: 10.1038/s41592-019-0617-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0617-2</ArticleId><ArticleId IdType="pmc">PMC7768885</ArticleId><ArticleId IdType="pubmed">31740818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon D, Tilgner H, Grubert F, Snyder M. A single-molecule long-read survey of the human transcriptome. Nat Biotechnol. 2013;31(11):1009&#x2013;1014. doi: 10.1038/nbt.2705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2705</ArticleId><ArticleId IdType="pmc">PMC4075632</ArticleId><ArticleId IdType="pubmed">24108091</ArticleId></ArticleIdList></Reference><Reference><Citation>Deveson IW, Brunck ME, Blackburn J, Tseng E, Hon T, Clark TA, et al. Universal alternative splicing of noncoding exons. Cell Syst. 2018;6(2):245&#x2013;55.e5. doi: 10.1016/j.cels.2017.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2017.12.005</ArticleId><ArticleId IdType="pubmed">29396323</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne A, Beaudin AE, Olsen HE, Jain M, Cole C, Palmer T, et al. Nanopore long-read RNAseq reveals widespread transcriptional variation among the surface receptors of individual B cells. Nat Commun. 2017;8:16027. doi: 10.1038/ncomms16027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16027</ArticleId><ArticleId IdType="pmc">PMC5524981</ArticleId><ArticleId IdType="pubmed">28722025</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilgner H, Grubert F, Sharon D, Snyder MP. Defining a personal, allele-specific, and single-molecule long-read transcriptome. Proc Natl Acad Sci U S A. 2014;111(27):9869&#x2013;9874. doi: 10.1073/pnas.1400447111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1400447111</ArticleId><ArticleId IdType="pmc">PMC4103364</ArticleId><ArticleId IdType="pubmed">24961374</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomopoulos S, Wang YC, Djambazian H, Badescu D, Ragoussis J. Benchmarking of the Oxford Nanopore MinION sequencing for quantitative and qualitative assessment of cDNA populations. Sci Rep. 2016;6:31602. doi: 10.1038/srep31602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31602</ArticleId><ArticleId IdType="pmc">PMC4995519</ArticleId><ArticleId IdType="pubmed">27554526</ArticleId></ArticleIdList></Reference><Reference><Citation>Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10(12):1213&#x2013;1218. doi: 10.1038/nmeth.2688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2688</ArticleId><ArticleId IdType="pmc">PMC3959825</ArticleId><ArticleId IdType="pubmed">24097267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, Simon I, et al. Genome-wide location and function of DNA binding proteins. Science. 2000;290(5500):2306&#x2013;2309. doi: 10.1126/science.290.5500.2306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.290.5500.2306</ArticleId><ArticleId IdType="pubmed">11125145</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman-Aiden E, van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science. 2009;326(5950):289&#x2013;293. doi: 10.1126/science.1181369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181369</ArticleId><ArticleId IdType="pmc">PMC2858594</ArticleId><ArticleId IdType="pubmed">19815776</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxi EG, Thompson T, Li J, Kaye JA, Lim RG, Wu J, et al. Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. Nat Neurosci. 2022;25(2):226&#x2013;237. doi: 10.1038/s41593-021-01006-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-01006-0</ArticleId><ArticleId IdType="pmc">PMC8825283</ArticleId><ArticleId IdType="pubmed">35115730</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuro LC, Li J, Lim RG, Kaye JA, Dardov V, Coyne AN, et al. An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients. iScience. 2021;24(11):103221. doi: 10.1016/j.isci.2021.103221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103221</ArticleId><ArticleId IdType="pmc">PMC8554488</ArticleId><ArticleId IdType="pubmed">34746695</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Cooper-Knock J, Weimer AK, Shi M, Moll T, Marshall JNG, et al. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis. Neuron. 2022;110(6):992&#x2013;1008.e11. doi: 10.1016/j.neuron.2021.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.12.019</ArticleId><ArticleId IdType="pmc">PMC9017397</ArticleId><ArticleId IdType="pubmed">35045337</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulchenko YS, de Koning DJ, Haley C. Genomewide rapid association using mixed model and regression: a fast and simple method for genomewide pedigree-based quantitative trait loci association analysis. Genetics. 2007;177(1):577&#x2013;585. doi: 10.1534/genetics.107.075614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.107.075614</ArticleId><ArticleId IdType="pmc">PMC2013682</ArticleId><ArticleId IdType="pubmed">17660554</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481&#x2013;487. doi: 10.1038/ng.3538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3538</ArticleId><ArticleId IdType="pubmed">27019110</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Kim D, Song J, Joo JWJ. An integrative transcriptome-wide analysis of amyotrophic lateral sclerosis for the identification of potential genetic markers and drug candidates. Int J Mol Sci. 2021;22(6):3216. doi: 10.3390/ijms22063216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063216</ArticleId><ArticleId IdType="pmc">PMC8004271</ArticleId><ArticleId IdType="pubmed">33809961</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L, Yuan Z, Jin S, Wang T, Huang S, Zeng P. Multiple-tissue integrative transcriptome-wide association studies discovered new genes associated with amyotrophic lateral sclerosis. Front Genet. 2020;11:587243. doi: 10.3389/fgene.2020.587243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.587243</ArticleId><ArticleId IdType="pmc">PMC7714931</ArticleId><ArticleId IdType="pubmed">33329728</ArticleId></ArticleIdList></Reference><Reference><Citation>Project Min EALSSC Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur J Hum Genet. 2018;26(10):1537&#x2013;1546. doi: 10.1038/s41431-018-0177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0177-4</ArticleId><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. Available from: https://www1.rarediseasesnetwork.org/cms/create. Cited 2022 26 September.</Citation></Reference><Reference><Citation>Libbrecht MW, Noble WS. Machine learning applications in genetics and genomics. Nat Rev Genet. 2015;16(6):321&#x2013;332. doi: 10.1038/nrg3920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3920</ArticleId><ArticleId IdType="pmc">PMC5204302</ArticleId><ArticleId IdType="pubmed">25948244</ArticleId></ArticleIdList></Reference><Reference><Citation>Reel PS, Reel S, Pearson E, Trucco E, Jefferson E. Using machine learning approaches for multi-omics data analysis: a review. Biotechnol Adv. 2021;49:107739. doi: 10.1016/j.biotechadv.2021.107739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biotechadv.2021.107739</ArticleId><ArticleId IdType="pubmed">33794304</ArticleId></ArticleIdList></Reference><Reference><Citation>Euesden J, Lewis CM, O'Reilly PF. PRSice: polygenic risk score software. Bioinformatics. 2015;31(9):1466&#x2013;1468. doi: 10.1093/bioinformatics/btu848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu848</ArticleId><ArticleId IdType="pmc">PMC4410663</ArticleId><ArticleId IdType="pubmed">25550326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genet. 2013;9(3):e1003348. doi: 10.1371/journal.pgen.1003348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003348</ArticleId><ArticleId IdType="pmc">PMC3605113</ArticleId><ArticleId IdType="pubmed">23555274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis ACF, Green RC. Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues. Genome Med. 2021;13(1):14. doi: 10.1186/s13073-021-00829-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-021-00829-7</ArticleId><ArticleId IdType="pmc">PMC7844961</ArticleId><ArticleId IdType="pubmed">33509269</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst. 2015;107(5):djv036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4754625</ArticleId><ArticleId IdType="pubmed">25855707</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye M, Abraham G, Nelson CP, Wood AM, Sweeting MJ, Dudbridge F, et al. Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention. J Am Coll Cardiol. 2018;72(16):1883&#x2013;1893. doi: 10.1016/j.jacc.2018.07.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.07.079</ArticleId><ArticleId IdType="pmc">PMC6176870</ArticleId><ArticleId IdType="pubmed">30309464</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50(9):1219&#x2013;1224. doi: 10.1038/s41588-018-0183-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0183-z</ArticleId><ArticleId IdType="pmc">PMC6128408</ArticleId><ArticleId IdType="pubmed">30104762</ArticleId></ArticleIdList></Reference><Reference><Citation>Restuadi R, Garton FC, Benyamin B, Lin T, Williams KL, Vinkhuyzen A, et al. Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia. Eur J Hum Genet. 2022;30(5):532&#x2013;539. doi: 10.1038/s41431-021-00885-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-021-00885-y</ArticleId><ArticleId IdType="pmc">PMC9090723</ArticleId><ArticleId IdType="pubmed">33907316</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51(4):584&#x2013;591. doi: 10.1038/s41588-019-0379-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0379-x</ArticleId><ArticleId IdType="pmc">PMC6563838</ArticleId><ArticleId IdType="pubmed">30926966</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>